Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Magnetic resonance outcome measures in multiple sclerosis trials — Massimo Filippi (2014) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Magnetic resonance outcome measures in multiple sclerosis trials
Shared by
Massimo Filippi
Magnetic resonance outcome measures in multiple sclerosis trials
Article
2014
en
Authors
Massimo Filippi
PP
Paolo Preziosa
MR
Maria A. Rocca
Abstract
1 min read
Trial outcomes in MS should include measures of inflammation and neurodegeneration, which should be combined according to the disease clinical phenotype, phase of the study, and the supposed mechanism of action of the drug tested.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2004
The use of magnetic resonance imaging in multiple sclerosis: lessons learned from clinical trials
Filippo Martinelli Boneschi
,
Marco Rovaris
,
Giancarlo Comi
,
Massimo Filippi
Article
2001
Diffusion tensor magnetic resonance imaging in multiple sclerosis
Massimo Filippi
,
Mara Cercignani
,
Matilde Inglese
,
Mark A. Horsfield
,
Giancarlo Comi
Article
2011
Magnetic Resonance Techniques in Multiple Sclerosis
Massimo Filippi
Article
2000
Enhanced magnetic resonance imaging in multiple sclerosis
Massimo Filippi
Article
2005
Functional magnetic resonance imaging and multiple sclerosis
Massimo Filippi
,
Maria A. Rocca
Discussion(0)
No comments yet. Be the first to comment.